The market is segmented based on , By function (reproduction, the cardiovascular system, metabolism, neuropeptide, incretin), Peptides (relaxin 1, 2, 3 and INSL (insulin-like peptide) 3, 4, 5 and 6), Sex (Men, Women), Synthesis (membranes, decidua, placenta and prostate), Drug (Serelaxin), End-Users (Clinics, Hospitals, Diagnostic centres, Home healthcare, others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
.
The data presented is for visualization purposes only and may not reflect actual results.
